Pharmaceutical composition for treating adverse reactions by...

Details Pharmaceutical composition for treating adverse reactions by... Pharmaceutical composition for treating adverse reactions by...

A - Human Necessities

61

K

A61K 31/7105 (2006.01) A61P 39/00 (2006.01)

Patent

CA 2751807

The invention relates to the use of an L-ribozyme, which is capable of splitting an L-RNA in the region of a target sequence of the L-RNA, in order to produce a pharmaceutical composition for treating undesired physiological adverse reactions due to the administration of a therapeutic molecule containing the L-RNA. Alternatively, an endogenous target RNA may also be split by the L-ribozyme.

L'invention concerne l'utilisation d'un L-ribozyme apte à diviser un L-ARN dans la zone d'une séquence cible du L-ARN pour porduire une composition pharmaceutique destinée au traitement de réactions secondaires physiologiques indésirables par apport d'une molécule thérapeutique contenant le L-ARN. Le L-ribozyme permet également de diviser une cible endogène d'ARN.

Affiliated with

Also associated with

Rating

Pharmaceutical composition for treating adverse reactions by... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition for treating adverse reactions by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for treating adverse reactions by... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1894732